WAT Overzicht aandelen
Waters Corporation biedt analytische workflowoplossingen in Azië, Noord- en Zuid-Amerika en Europa. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Waters Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$357.77 |
| 52 Week Hoogtepunt | US$393.38 |
| 52 Week Laag | US$273.60 |
| Bèta | 0.97 |
| 11 maand verandering | 3.55% |
| 3 maanden verandering | 6.45% |
| 1 Jaar Verandering | 29.47% |
| 33 jaar verandering | 4.04% |
| 5 jaar verandering | 60.04% |
| Verandering sinds IPO | 9,361.69% |
Recent nieuws en updates
Is Waters (NYSE:WAT) A Risky Investment?
Nov 21
Waters Corp: Short Reinvestment Runway Diminishes High Multiples
Nov 13Recent updates
Is Waters (NYSE:WAT) A Risky Investment?
Nov 21Waters Corp: Short Reinvestment Runway Diminishes High Multiples
Nov 13Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings
Sep 11A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Aug 24Waters Corp.: Embedded Expectations High Under Present Conditions
Aug 15Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?
Aug 06Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Jul 19Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price
May 26Waters Corporation: Still Struggling A Bit
May 24Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 25Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?
Apr 07We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt
Mar 19Waters Corporation: A Great (Share Price) Run
Mar 11Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323
Feb 09Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings
Jan 09Waters Corporation: High Quality Niche Company In Mass Spectrometry
Dec 28A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Dec 10Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Nov 25Waters Corporation: Appealing Levels Are Offset By Weaker Performance
Nov 13Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly
Oct 26Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)
Sep 27What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?
Aug 21Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Aug 03Waters Corporation: Temporary Headwinds Present A Buying Opportunity
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jul 16Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
May 23A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 29Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly
Apr 08What Is Waters Corporation's (NYSE:WAT) Share Price Doing?
Feb 22Waters Q4 2022 Earnings Preview
Feb 14Waters Corp.: Now Best Price-Positioned Medical Services Stock
Feb 02Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 26Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?
Jan 05Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Nov 24Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363
Nov 16Waters Q3 2022 Earnings Preview
Oct 31Estimating The Fair Value Of Waters Corporation (NYSE:WAT)
Oct 19Waters announces €6M R&D investment at Wexford facility
Oct 07Is Waters (NYSE:WAT) Using Too Much Debt?
Oct 01Do Waters' (NYSE:WAT) Earnings Warrant Your Attention?
Aug 23Waters Corporation: Thesis Unchanged
Aug 18Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Aug 05Rendement voor aandeelhouders
| WAT | US Life Sciences | US Markt | |
|---|---|---|---|
| 7D | -7.2% | -5.8% | -1.0% |
| 1Y | 29.5% | 1.7% | 30.3% |
Rendement versus industrie: WAT overtrof de US Life Sciences industrie, die het afgelopen jaar een rendement 1.7 % opleverde.
Rendement versus markt: WAT kwam overeen met de US markt, die het afgelopen jaar een rendement opleverde van 30.3 %.
Prijsvolatiliteit
| WAT volatility | |
|---|---|
| WAT Average Weekly Movement | 6.5% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: WAT heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van WAT is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1958 | 7,900 | Udit Batra | www.waters.com |
Waters Corporation levert analytische workflowoplossingen in Azië, Noord- en Zuid-Amerika en Europa. Het bedrijf opereert via twee segmenten: Waters en TA. Het bedrijf ontwerpt, produceert, verkoopt en onderhoudt hoge- en ultraperformante vloeistofchromatografie en massaspectrometrie (MS) technologiesystemen en ondersteunende producten, waaronder chromatografiekolommen, andere verbruiksproducten en servicepakketten na garantie.
Waters Corporation Samenvatting
| WAT fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$20.47b |
| Inkomsten(TTM) | US$622.64m |
| Inkomsten(TTM) | US$2.91b |
34.1x
Koers/Winstverhouding7.3x
P/S-verhoudingIs WAT overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| WAT resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$2.91b |
| Kosten van inkomsten | US$1.17b |
| Brutowinst | US$1.74b |
| Overige uitgaven | US$1.11b |
| Inkomsten | US$622.64m |
Laatst gerapporteerde inkomsten
Sep 28, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 10.49 |
| Brutomarge | 59.73% |
| Nettowinstmarge | 21.43% |
| Schuld/Eigen Vermogen Verhouding | 115.6% |
Hoe presteerde WAT op de lange termijn?
Bekijk historische prestaties en vergelijking